Checkpoint

Checkpoint Therapeutics was a biopharmaceutical company focused on developing therapeutic antibodies and targeted small molecule inhibitors for oncology treatment. The company maintained a pipeline of drug candidates in various stages of clinical development before being acquired by Sun Pharma in 2025. UpGuard continuously monitors the security posture of Checkpoint using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Checkpoint Security Rating

X
---
/ 950
Checkpoint's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Checkpoint.

Company info

Checkpoint
Company
Checkpoint
Employees
Location
CEO
Last updated
Last updated
Industries
Last updated today

Checkpoint Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Checkpoint's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Checkpoint Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Checkpoint.

Security reports related to Checkpoint

Compare Checkpoint's security performance with other companies in their industry.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating